Resmed Inc. [RMD] stock prices are down -3.56% to $215.68 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RMD shares have gain 3.42% over the last week, with a monthly amount glided 10.75%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Resmed Inc. [NYSE: RMD] stock has seen the most recent analyst activity on June 25, 2024, when Oppenheimer downgraded its rating to a Perform. Previously, Citigroup downgraded its rating to Neutral on June 24, 2024. Morgan Stanley upgraded its rating to a Overweight and decreased its price target to $169 on October 27, 2023. RBC Capital Mkts downgraded its rating to a Sector Perform and reduced its price target to $202 on October 12, 2023. JP Morgan upgraded its rating to Overweight for this stock on October 09, 2023, and downed its price target to $170. In a note dated September 29, 2023, Wolfe Research downgraded an Peer Perform rating on this stock.
The stock price of Resmed Inc. [RMD] has been fluctuating between $132.24 and $225.68 over the past year. Currently, Wall Street analysts expect the stock to reach $209.33 within the next 12 months. Resmed Inc. [NYSE: RMD] shares were valued at $215.68 at the most recent close of the market. An investor can expect a potential drop of -2.94% based on the average RMD price forecast.
Analyzing the RMD fundamentals
The Resmed Inc. [NYSE:RMD] reported sales of 4.69B for trailing twelve months, representing a surge of 9.01%. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.22%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.22 and Total Capital is 0.22. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 209.72 points at the first support level, and at 203.76 for the second support level. However, for the 1st resistance point, the stock is sitting at 220.92, and for the 2nd resistance point, it is at 226.16.
Ratios To Look Out For
It’s worth pointing out that Resmed Inc. [NYSE:RMD]’s Current Ratio is 2.59. As well, the Quick Ratio is 1.69, while the Cash Ratio is 0.26. Considering the valuation of this stock, the price to sales ratio is 6.76, the price to book ratio is 6.84 and price to earnings (TTM) ratio is 31.16.
Transactions by insiders
Recent insider trading involved Leong Justin, Officer, that happened on Aug 05 ’24 when 48000.0 shares were purchased. Chief Executive Officer, Farrell Michael J. completed a deal on Jul 08 ’24 to sell 14683.0 shares. Meanwhile, Chief Financial Officer Sandercock Brett sold 1000.0 shares on Jul 08 ’24.
